# Pharmaplast S.A.E. – FDA Inspection, Feb 6, 2025

Source: https://www.keypedia.com/records/fda_inspections/pharmaplast-sae/c3108f0c-4c43-438e-b05d-11df155af929
Source feed: FDA_Inspections

> FDA inspection 1260910 of Pharmaplast S.A.E., February 06, 2025. Classification: Official Action Indicated (OAI). 7 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260910
- Company Name: Pharmaplast S.A.E.
- Inspection Date: 2025-02-06
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- [FDA Inspection 1190349 - 2022-11-10](https://www.keypedia.com/records/fda_inspections/pharmaplast-sae/d8a31311-5b8f-4f3f-8de7-e2bc2061824b)

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/pharmaplast-sae/69fdda1e-d63c-4bd4-b5ed-402c137267a5

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8